Facing funding challenges? This blog from Harvard Bioscience explores diverse alternative funding sources for researchers—from private foundations and industry partnerships to international grants and crowdfunding. It also highlights key awards supporting early-career scientists. Discover practical paths to keep your research moving forward, even in uncertain times.
In a move that could reshape the landscape of preclinical drug development, the Food and Drug Administration (FDA) recently announced a plan to phase out its requirement for use of animal models in evaluating monoclonal antibodies (mAbs) and other drug candidates.
The SoHo Telemetry System revolutionizes small animal model research by enabling real-time physiological monitoring alongside behavioral analysis without disrupting natural movement. With wireless efficiency, extended transmission distance, and seamless integration, SoHo enhances studies in stress, neuroscience, sleep, motor disorders, cognition, and metabolism. Researchers gain greater accuracy, efficiency, and reproducibility, making SoHo a game-changer in preclinical research.
A recent study from Great Ormond Street Hospital suggests that commonly prescribed nitrogen scavengers for Urea Cycle Disorders (UCD) may contribute to Branch Chain Amino Acid (BCAA) depletion, highlighting the need for a balanced approach that optimizes protein intake and considers alternative treatments.
DSI's SoHo Implantable Telemetry platform revolutionizes small animal research by enabling comprehensive biopotential monitoring. Capture EEG, EMG, ECG, body temperature, and locomotor activity with minimal invasiveness. Designed for extra-small to medium animal models, this system enhances research precision, reduces experimental stress, and provides unprecedented insights across neuroscience, cardiovascular, and behavioral studies.
Organoid electrophysiology is providing pharmaceutical and biotech companies with human-relevant models for testing drug efficacy, modeling diseases, and reducing reliance on animal studies, ultimately accelerating the development of safer and more effective therapeutics.
Wildfire smoke poses a growing public health threat, with harmful pollutants like PM2.5 linked to respiratory and cardiovascular issues. This blog explores the health impacts of wildfire smoke, highlights recent research advancements, and showcases innovative tools like DSI’s inhalation exposure systems and telemetry solutions. Discover how these technologies are helping researchers uncover the mechanisms behind smoke-related health risks and develop interventions to protect vulnerable populations.
The integration of behavioral telemetry and organoid research is transforming neuroscience and biomedical science by linking cellular models with complex biological behaviors.
Revolutionize your diabetes research with DSI’s continuous glucose telemetry system. This innovative technology enables real-time, long-term glucose monitoring in animal models, offering stress-free, comprehensive data collection. By bridging preclinical and clinical research, it supports breakthroughs in glycemic control and translational therapies. Learn how it’s shaping the future of diabetes treatments.
